Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 2
2004 3
2005 2
2006 5
2007 6
2008 15
2009 16
2010 22
2011 16
2012 18
2013 30
2014 36
2015 42
2016 36
2017 38
2018 41
2019 43
2020 47
2021 59
2022 70
2023 75
2024 30

Text availability

Article attribute

Article type

Publication date

Search Results

578 results

Results by year

Filters applied: . Clear all
Page 1
The birth of artemisinin.
Ma N, Zhang Z, Liao F, Jiang T, Tu Y. Ma N, et al. Pharmacol Ther. 2020 Dec;216:107658. doi: 10.1016/j.pharmthera.2020.107658. Epub 2020 Aug 8. Pharmacol Ther. 2020. PMID: 32777330 Review.
Immune Checkpoint LAG3 and Its Ligand FGL1 in Cancer.
Shi AP, Tang XY, Xiong YL, Zheng KF, Liu YJ, Shi XG, Lv Y, Jiang T, Ma N, Zhao JB. Shi AP, et al. Among authors: ma n. Front Immunol. 2022 Jan 17;12:785091. doi: 10.3389/fimmu.2021.785091. eCollection 2021. Front Immunol. 2022. PMID: 35111155 Free PMC article. Review.
Petal senescence: a hormone view.
Ma N, Ma C, Liu Y, Shahid MO, Wang C, Gao J. Ma N, et al. J Exp Bot. 2018 Feb 12;69(4):719-732. doi: 10.1093/jxb/ery009. J Exp Bot. 2018. PMID: 29425359 Review.
Study towards improving artemisinin-based combination therapies.
Lyu HN, Ma N, Meng Y, Zhang X, Wong YK, Xu C, Liao F, Jiang T, Tu Y, Wang J. Lyu HN, et al. Among authors: ma n. Nat Prod Rep. 2021 Jul 21;38(7):1243-1250. doi: 10.1039/d0np00079e. Nat Prod Rep. 2021. PMID: 34287440 Review.
The Proliferative Role of Immune Checkpoints in Tumors: Double Regulation.
Tang XY, Luo ZL, Xiong YL, Yang J, Shi AP, Zheng KF, Liu YJ, Shu C, Ma N, Lu Q, Zhao JB. Tang XY, et al. Among authors: ma n. Cancers (Basel). 2022 Oct 31;14(21):5374. doi: 10.3390/cancers14215374. Cancers (Basel). 2022. PMID: 36358792 Free PMC article. Review.
578 results